|
|
Volumn 92, Issue 6, 2003, Pages 645-646
|
|
The Second International Consultation on Erectile Dysfunction: Highlights from the pharmaceutical industry
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOMORPHINE;
ATIPAMEZOLE;
BOTULINUM TOXIN A;
DOPAMINE RECEPTOR STIMULATING AGENT;
N ACETYLNORLEUCYLASPARTYLHISTIDYL DEXTRO PHENYLALANYLARGINYLTRYPTOPHYLLYSINE 2,7 CYCLIC AMIDE;
NMI 870;
PHOSPHODIESTERASE INHIBITOR;
SILDENAFIL;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
DATA BASE;
DRUG INDUSTRY;
DRUG ISOLATION;
DRUG MARKETING;
ERECTILE DYSFUNCTION;
FEMALE SEXUAL DYSFUNCTION;
HUMAN;
MEDICAL LITERATURE;
NAUSEA;
PRIORITY JOURNAL;
REVIEW;
SCREENING;
SIDE EFFECT;
CONGRESSES;
DRUG INDUSTRY;
FEMALE;
HUMANS;
IMPOTENCE;
MALE;
SEXUAL AND GENDER DISORDERS;
|
|
EID: 0142092262
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410X.2003.04447.x Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
